Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 14 of 14 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 05/01/26
Due: 05/01/27
Phase: N/A
Priority: Normal
Start: 08/24/22
End: 09/05/23
Due: 09/05/24
Phase: N/A
Priority: Normal
Start: 11/10/22
End: 04/15/25
Due: 04/15/26
Phase: N/A
Priority: Normal
Start: 04/10/25
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 07/18/23
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 05/06/24
Due: 05/06/25
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 07/10/24
End: 10/10/28
Due: 10/10/29
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 02/28/27
Due: 02/28/28
A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.
Phase: N/A
Priority: Normal
Start: 04/30/25
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 07/01/25
Due: 07/01/26
Phase: N/A
Priority: Normal
Start: 09/13/23
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 02/01/25
End: 10/26/28
Due: 10/26/29
Phase: N/A
Priority: Normal
Start: 03/24/25
End: 06/30/29
Due: 06/30/30